Molecular pathways: response and resistance to BRAF and MEK inhibitors in BRAF(V600E) tumors (Q38172419)

30 August 2017

title

Molecular pathways: response and resistance to BRAF and MEK inhibitors in BRAF(V600E) tumors (English)

1 reference

30 August 2017

Meghna Das Thakur

1 reference

30 August 2017

Darrin D Stuart

series ordinal

1 reference

30 August 2017

language of work or name

English

0 references

publication date

18 December 2013

1 reference

30 August 2017

published in

Clinical Cancer Research

1 reference

30 August 2017

1 reference

30 August 2017

1 reference

30 August 2017

page(s)

1074-1080

1 reference

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

30 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE11003

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1158/1078-0432.CCR-13-0103

1 reference

30 August 2017

1 reference